Table 2.
Anticoagulant use and cost in the cardiology unit (n = 132).
| Characteristics | Categories | n (%) |
|---|---|---|
| Prescribed anticoagulants | Unfractionated heparin (UFH) | 4 (3.03) |
| Unfractionated heparin + enoxaparin | 60 (45.45) | |
| Enoxaparin | 36 (27.3) | |
| Enoxaparin + warfarin | 21 (15.90) | |
| Warfarin | 6 (4.54) | |
| Dabigatran | 5 (3.78) | |
| Indication of anticoagulants use | Acute coronary syndrome (ACS) | 88 (66.67) |
| Congestive heart failure (CHF) | 40 (30.30) | |
| Rheumatic heart disease (RHD) | 4 (3.03) | |
| †Individual drug cost | $0.03 to $126.24 | $79.92 ($46.32) |
†Median (IQR) instead of n (%); IQR: interquartile range. 1$ (USD) = 114.05 Nepalese rupees (NRs) during the study period.